articleBMC Complementary and Alternative MedicineMar 17, 2006GOLD OA

Dose escalation of a curcuminoid formulation

University of Michigan · Michigan Medicine · +3 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Background

Curcumin is the major yellow pigment extracted from turmeric, a commonly-used spice in India and Southeast Asia that has broad anticarcinogenic and cancer chemopreventive potential. However, few systematic studies of curcumin's pharmacology and toxicology in humans have been performed.

Methods

A dose escalation study was conducted to determine the maximum tolerated dose and safety of a single dose of standardized powder extract, uniformly milled curcumin (C3 Complextrade mark, Sabinsa Corporation). Healthy volunteers were administered escalating doses from 500 to 12,000 mg.

Citation impact

1,372
total citations
FWCI
9.58
Percentile
100%
References
22
Citations per year

Authors

10

Topics & keywords

Keywords
  • Curcumin
  • Curcuminoid
  • Medicine
  • Bioavailability
  • Pharmacology
  • Traditional medicine
  • Toxicity
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding